Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

Related Articles by Review for PubMed (Select 11458138)

1.

Multicomponent targeted intervention to prevent delirium in hospitalized older patients: what is the economic value?

Rizzo JA, Bogardus ST Jr, Leo-Summers L, Williams CS, Acampora D, Inouye SK.

Med Care. 2001 Jul;39(7):740-52.

PMID:
11458138
2.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

3.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
4.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

5.

Cost-effectiveness of multi-component interventions to prevent delirium in older people admitted to medical wards.

Akunne A, Murthy L, Young J.

Age Ageing. 2012 May;41(3):285-91. doi: 10.1093/ageing/afr147. Epub 2012 Jan 26. Review.

6.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

7.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

8.

Multicomponent intervention strategies for managing delirium in hospitalized older people: systematic review.

Milisen K, Lemiengre J, Braes T, Foreman MD.

J Adv Nurs. 2005 Oct;52(1):79-90. Review.

PMID:
16149984
9.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

10.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

11.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

12.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
14.

Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness.

Johnson-Masotti AP, Weinhardt LS, Pinkerton SD, Otto-Salaj LL.

J Ment Health Policy Econ. 2003 Mar;6(1):23-35. Review.

PMID:
14578545
15.

Delirium and the older adult after surgery.

Dibert C.

Perspectives. 2004 Spring;28(1):10-6. Review.

PMID:
15315205
16.

The cost-effectiveness of screening for oral cancer in primary care.

Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F.

Health Technol Assess. 2006 Apr;10(14):1-144, iii-iv. Review.

17.

Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation.

Strickland A, Brogan A, Krauss J, Martindale R, Cresci G.

JPEN J Parenter Enteral Nutr. 2005 Jan-Feb;29(1 Suppl):S81-91. Review.

PMID:
15709550
18.

Stroke rehabilitation services to accelerate hospital discharge and provide home-based care: an overview and cost analysis.

Anderson C, Ni Mhurchu C, Brown PM, Carter K.

Pharmacoeconomics. 2002;20(8):537-52. Review.

PMID:
12109919
19.

Delirium in the elderly: a clinical review.

Saxena S, Lawley D.

Postgrad Med J. 2009 Aug;85(1006):405-13. doi: 10.1136/pgmj.2008.072025. Review.

PMID:
19633006
20.

Synopsis of the National Institute for Health and Clinical Excellence guideline for prevention of delirium.

O'Mahony R, Murthy L, Akunne A, Young J; Guideline Development Group.

Ann Intern Med. 2011 Jun 7;154(11):746-51. doi: 10.7326/0003-4819-154-11-201106070-00006.

PMID:
21646557
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk